The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA. It operates through the Human Health and Animal Health segments. JAGUAR HEALTH: Subsidiary Receiving Preclinical Services from the National Institute of Allergy and Infectious Diseases for New Preclinical Study Initiated January 6, 2021 for Lechlemer Plant-Based Drug Candidate for the Symptomatic Relief of Diarrhea from Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqCM - NasdaqCM Real Time Price. About Jaguar Health, Inc. and Napo Pharmaceuticals, Inc. Jaguar Health, Inc. is a commercial stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. As of Sep 29, 2020, the company held 0.57% of the shares, roughly 393.39 Thousand JAGX shares worth $113.89 Thousand. Cookie Notice. By using this site you agree to the
Get the latest Jaguar Health Inc (JAGX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Jaguar Health continues to heat up, but JAGX stock is moving higher on a lot of hope. Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. Rule out infectious etiologies of diarrhea before starting MYTESI ®. Jaguar Health Inc. JAGX 3.82 0.13 (3.52%). Copyright © 2021 MarketWatch, Inc. All rights reserved.
NasdaqCM - NasdaqCM Real Time Price. View real-time stock prices and stock quotes for a full financial overview. On Friday, Jaguar Health Inc gained another 49.25% to close the trading week at $4.00 per share as the stock hit an all new 52-week high of $4.47, before settling back down to the closing price. Jaguar Health Inc. Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. NEW YORK, Jan. 13, 2021 /PRNewswire via COMTEX/ -- NEW YORK, Jan. 13, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for JAGX, DFFN, FCEL, EMAN, and FLNT. Item 7.01 Regulation FD Disclosure. Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. *Indication MYTESI ® is an antidiarrheal indicated for the symptomatic relief of noninfectious diarrhea in adult patients with HIV/AIDS on antiretroviral therapy (ART).. All quotes are in local exchange time. Banned List, Welcome to the Roaring ’20s, but Maybe Not for Stocks, Our Experts Say, As U.S. Fights Today’s Problems, Tomorrow’s Inflation Starts to Stir. Press Release reported 8 hours ago that Jaguar Health to Host Investor Call Monday, November 16th at 8:30 a.m. Eastern Regarding Q3 2020 Financials & Business Updates The company’s stock price has collected 0.55% of gains in the last five trading sessions. Something went wrong while loading Watchlist. Stock analysis for Jaguar Health Inc (JAGX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Jaguar Health, Inc. (JAGX) Add to watchlist. Intraday data delayed at least 15 minutes or per exchange requirements. Get Our PREMIUM Forecast Now, from ONLY $6.69! InvestorsObserver’s proprietary ranking system, gives JAGX stock a score of 88 out of a possible 100. The company’s stock has been forecasted to trade at an average price of $5 over the course of the next 52 weeks, with a low of $5 and a high of $5. This additional non-dilutive financing will support development program for lechlemer for the indication of the symptomatic relief of diarrhea and dehydration in cholera patientsREMINDER: Jaguar-hosted investor webcast scheduled for Thursday, January 14 at 11:30 A. Webcast registration and participation link appears belowSAN FRANCISCO, CA / ACCESSWIRE / January 13, 2021 / Jaguar Health, Inc. PAHC: What does Argus have to say about PAHC? Have Watchlists? Log in to see them here or sign up to get started. This browser is no longer supported at MarketWatch. If you are looking for stocks with good return, Jaguar Health Inc stock can be a bad, high-risk 1-year investment option. - Try Now Risk-Free - Money-back guarantee! © 2021 Verizon Media. Jaguar Health, Inc. operates as a natural-products pharmaceutical company. Jaguar Health - Jaguar Health. Tanger Factory Outlet Centers Brings Back Its Dividend, These money and investing tips can help you give your portfolio free rein, Big Pension Bought Up Tesla, Apple, Microsoft, and GE Stock, These Chinese Companies Were Added to the U.S. On January 11, 2021, Jaguar Health, Inc. (the "Company") issued a press release announcing its plans to explore the possibility of obtaining conditional marketing authorization in Europe to support development and commercialization of crofelemer, the Company's novel proprietary drug, for the proposed indication of prophylaxis and/or symptomatic relief … The company has a Forward Dividend ratio of 0, with its dividend yield at 0%. JAGX | Complete Jaguar Health Inc. stock news by MarketWatch. There are 15 institutions holding the Jaguar Health, Inc. stock share, with Virtu Financial LLC the top institutional holder. He’s pinpointed 23 recommendations that went on to soar 1,000% or more. Here’s Why It Could Shoot Up Higher. There are currently no items in this Watchlist. Find real-time JAGX - Jaguar Health Inc stock quotes, company profile, news and forecasts from CNN Business. Currency in USD, Trade prices are not sourced from all markets, Legendary Stock-Picker Names Favorite Stock of ‘21.